Lehman's increased stake and board seats give him significant influence over strategic decisions, including potential M&A or capital allocation. Watch for further 13D amendments detailing specific demands or a proxy fight if the company resists his agenda.
Price Chart
Executive Summary
Kenneth R. Lehman filed an amended Schedule 13D disclosing a significant increase in his stake in BayFirst Financial Corp. to 12,249,535 shares (39.42% of common stock), up from a prior position. The increase was driven by the acquisition of 749,535 shares as the backstop purchaser in the company's recent rights offering on October 8, 2026. Lehman, already a board member, maintains sole voting and investment control and has gross-up rights to maintain his ownership percentage in future equity offerings, signaling continued activist involvement and potential for further influence.
Key Financial Metrics
Key Facts
- Kenneth R. Lehman now beneficially owns 12,249,535 shares of BayFirst Financial Corp. common stock, representing 39.42% of outstanding shares.
- Lehman acquired 749,535 shares as the backstop purchaser in the company's recent rights offering, using personal and Roth IRA funds, on October 8, 2026.
- Lehman has sole voting and investment power over all shares; 8,012,430 shares are held personally and 4,237,205 shares are held in his Roth IRA.
- Lehman has gross-up rights to acquire additional equity or equity-linked securities to maintain his proportionate ownership in future offerings.
- Lehman is a member of the boards of directors of both BayFirst Financial Corp. and its subsidiary, BayFirst National Bank.
Financial Impact
Lehman increased his stake by 749,535 shares via the rights offering backstop; total stake value is not disclosed but represents 39.42% of the company's common equity.
Risk Factors
- Lehman's large stake and gross-up rights could lead to further dilution for minority shareholders if additional equity offerings are structured to maintain his percentage.
- Potential for activist pressure or board conflict if Lehman's strategic vision diverges from management's.
- The rights offering backstop indicates the company needed capital support, which may signal underlying financial strain.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001649739-26-000137 |
| Document: 0001649739-26-000137-index.html | 0001649739-26-000137 |
| Document: 0001649739-26-000137.txt | 0001649739-26-000137 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | SC 13D/A | $6.44 | awaiting T+60 | — | $6.02 (−6.52%) |
Oct 13, 2026 14d ago | SC 13D/A | $5.25 | awaiting T+60 | — | $6.02 (+14.67%) |
Sep 30, 2026 27d ago | 8-K | $6.81 | awaiting T+60 | — | $6.02 (−11.60%) |
Sep 29, 2026 28d ago | 8-K | $7.21 | awaiting T+60 | — | $6.02 (−16.50%) |
Sep 24, 2026 4w ago | 3 | $7.12 | awaiting T+60 | — | $6.02 (−15.45%) |
Sep 24, 2026 4w ago | Press Release | $7.12 | awaiting T+60 | — | $6.02 (−15.45%) |
Sep 1, 2026 8w ago | 8-K | $7.15 | awaiting T+60 | — | $6.02 (+15.80%) |
Aug 27, 2026 8w ago | 8-K | $6.61 | awaiting T+60 | — | $6.02 (−8.93%) |
Aug 25, 2026 9w ago | EFFECT | $7.37 | awaiting T+60 | — | $6.02 (+18.32%) |
Aug 21, 2026 9w ago | S-1/A | $7.31 | awaiting T+60 | — | $6.02 (+17.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers